PET/CT with18F Fluorocholine as an Imaging Biomarker for Chronic Liver Disease: A Preliminary Radiopathologic Correspondence Study in Patients with Liver Cancer

Authors:

Abstract
In patients with liver cancer who undergo 18F fluorocholine PET/CT before surgery, levels of hepatic 18F fluorocholine uptake differed significantly in degrees of liver fibrosis and necroinflammation, as assessed postoperatively in peritumoral liver tissue. PurposeTo determine the relationship between hepatic uptake at preoperative fluorine 18 (18F) fluorocholine combined positron emission tomography (PET) and computed tomography (CT) and the histopathologic features of chronic liver disease in patients with Child-Pugh class A or B disease who are undergoing hepatic resection for liver cancer.Materials and MethodsForty-eight patients with resectable liver tumors underwent preoperative 18F fluorocholine PET/CT. Mean liver standardized uptake value (SUVmean) measurements were obtained from PET images, while histologic indexes of inflammation and fibrosis were applied to nontumor liver tissue from resection specimens. Effects of histopathologic features on liver SUVmean were examined with analysis of variance.ResultsLiver SUVmean ranged from 4.3 to 11.6, correlating significantly with Knodell histologic activity index (ρ = −0.81, P < .001) and several clinical indexes of liver disease severity. Liver SUVmean also differed significantly across groups stratified ...
Funding Information
  • National Cancer Institute (R01CA161209-06)

This publication has 35 references indexed in Scilit: